Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 4
Submit an article Journal homepage
1,445
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season

Laurence Serradella Risk-Benefit & Epidemiology, Sanofi Pasteur, Campus Sanofi Lyon, Lyon, FranceCorrespondence[email protected]
View further author information
,
Sophie Waguéb Medical Operations, Sanofi Pasteur, Campus Sanofi Lyon, Lyon, FranceView further author information
,
Annick Moureauc Global Biostatistical Sciences, Sanofi Pasteur, Marcy l’EtoileFranceORCID Iconhttps://orcid.org/0000-0002-5306-2833View further author information
ORCID Icon,
Markku Nissiläd Terveystalo Clinical Research and Biobank, Turku, FinlandORCID Iconhttps://orcid.org/0000-0002-3327-0141View further author information
ORCID Icon &
Anne-Laure Chabanone Global Pharmacovigilance, Sanofi Pasteur, Campus Sanofi Lyon, Lyon, FranceView further author information
Pages 1205-1210 | Received 14 Apr 2020, Accepted 28 Jul 2020, Published online: 23 Sep 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Huakun Lv, Xuejiao Pan, Hui Liang, Ying Wang & Yu Hu. (2021) Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine. Human Vaccines & Immunotherapeutics 17:11, pages 4617-4622.
Read now

Articles from other publishers (5)

Sunho Choe, Oxana Talanova, Sooyoun Shin, Olga Syrkina & Marion Fournier. (2023) Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea. Infectious Diseases and Therapy 12:6, pages 1715-1723.
Crossref
Lindsay N. Avolio, Tyler J. S. Smith, Ana Navas‐Acien, Kate Kruczynski, Nora Pisanic, Pranay R. Randad, Barbara Detrick, Rebecca C. Fry, Alexander van Geen, Walter Goessler, Ruth A. Karron, Sabra L. Klein, Elizabeth L. Ogburn, Marsha Wills‐Karp, Kelsey Alland, Kaniz Ayesha, Brian Dyer, Md. Tanvir Islam, Habibat A. Oguntade, Md. Hafizur Rahman, Hasmot Ali, Rezwanul Haque, Saijuddin Shaikh, Kerry J. Schulze, A. K. M. Muraduzzaman, A. S. M. Alamgir, Meerjady S. Flora, Keith P. WestJr.Jr., Alain B. Labrique & Christopher D. Heaney. (2023) The Pregnancy, Arsenic, and Immune Response (PAIR) Study in rural northern Bangladesh. Paediatric and Perinatal Epidemiology 37:2, pages 165-178.
Crossref
Sonja Gandhi‐Banga, Sophie Wague, Anju Shrestha, Olga Syrkina, Oxana Talanova, Markku Nissilä, Karl Stuff & Céline Monfredo. (2022) Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22. Influenza and Other Respiratory Viruses 17:1.
Crossref
Melanie Moeller-Arendt, Serge van de Witte, Jos Nauta, Hanka de Voogd, Jutta Rogoll & Thomas Nisslein. (2023) Enhanced passive safety surveillance of Influvac® and Influvac® Tetra: Results from seven consecutive seasons. Vaccine 41:2, pages 606-613.
Crossref
Sookyung Lim, Xiaoling Li, Olga Syrkina & Marion Fournier. (2022) Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea. Infectious Diseases and Therapy 11:5, pages 2035-2043.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.